Lescar Julien, Sanchez Jean-Frederic, Audfray Aymeric, Coll Jean-Luc, Breton Christelle, Mitchell Edward P, Imberty Anne
Centre de Recherches sur les Macromolécules Végétales, CNRS, BP53, 38041 Grenoble Cedex 09, France.
Glycobiology. 2007 Oct;17(10):1077-83. doi: 10.1093/glycob/cwm077. Epub 2007 Jul 25.
Helix pomatia agglutinin (HPA) is a lectin that has been used extensively in histopathology, since its binding to tissue sections from breast and colon cancers is correlated with the worst prognosis for the patients. The lectin recognizes alpha-d-N-acetylgalactosamine (alphaGalNAc) containing epitopes which are only present in cancer cell lines having a high likelihood to undergo metastasis, such as the HT29 cancer colon cell line. Several breast cancer cell lines have also been shown to be labeled, although IGROV1, an ovarian cancer cell line, is not. Inhibition studies, using GalNAc monosaccharides, are reported here, showing that the labeling is dependent upon the presence of carbohydrate epitopes. The crystal structures of the lectin complexed with two GalNAc containing epitopes associated with cancer, the Tn (alphaGalNAc-Ser) and Forssman (alphaGalNAc1-3GalNAc) antigens, show the lectin's specificity for GalNAc is due to a particular network of hydrogen bonds. A histidine residue makes hydrophobic contact with the aglycon, rationalizing the preference for GalNAc bearing an additional sugar or amino acid in the alpha position. These structures provide the molecular basis for the use of HPA in metastasis research.
锥螺凝集素(HPA)是一种在组织病理学中被广泛应用的凝集素,因为它与乳腺癌和结肠癌组织切片的结合与患者的最差预后相关。该凝集素识别含有α - d - N - 乙酰半乳糖胺(αGalNAc)的表位,这些表位仅存在于具有高转移可能性的癌细胞系中,如HT29结肠癌细胞系。尽管卵巢癌细胞系IGROV1没有被标记,但也有几种乳腺癌细胞系被证明可被标记。本文报道了使用GalNAc单糖的抑制研究,结果表明标记依赖于碳水化合物表位的存在。该凝集素与两种与癌症相关的含GalNAc表位(Tn(αGalNAc - Ser)和Forssman(αGalNAc1 - 3GalNAc)抗原)形成的复合物的晶体结构表明,凝集素对GalNAc的特异性归因于特定的氢键网络。一个组氨酸残基与糖苷配基形成疏水接触,这解释了对在α位带有额外糖或氨基酸的GalNAc的偏好。这些结构为HPA在转移研究中的应用提供了分子基础。